BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Putra M, Puttachary S, Liu G, Lee G, Thippeswamy T. Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis. Front Cell Neurosci 2020;14:592374. [PMID: 33363455 DOI: 10.3389/fncel.2020.592374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Morey N, Przybyla M, van der Hoven J, Ke YD, Delerue F, van Eersel J, Ittner LM. Treatment of epilepsy using a targeted p38γ kinase gene therapy. Sci Adv 2022;8. [DOI: 10.1126/sciadv.add2577] [Reference Citation Analysis]
2 Gage M, Vinithakumari AA, Mooyottu S, Thippeswamy T. Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration. Front Microbiom 2022;1. [DOI: 10.3389/frmbi.2022.1006078] [Reference Citation Analysis]
3 Wang Y, Li C, Xiong Z, Chen N, Wang X, Xu J, Wang Y, Liu L, Wu H, Huang C, Huang A, Tan J, Li Y, Li Q. Up-and-coming anti-epileptic effect of aloesone in Aloe vera: Evidenced by integrating network pharmacological analysis, in vitro, and in vivo models. Front Pharmacol 2022;13:962223. [DOI: 10.3389/fphar.2022.962223] [Reference Citation Analysis]
4 del Pozo A, Lehmann L, Knox KM, Barker-haliski M. Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy. Front Neurol 2022;13:833624. [DOI: 10.3389/fneur.2022.833624] [Reference Citation Analysis]
5 Wang S, Wang B, Shang D, Zhang K, Yan X, Zhang X. Ion Channel Dysfunction in Astrocytes in Neurodegenerative Diseases. Front Physiol 2022;13:814285. [PMID: 35222082 DOI: 10.3389/fphys.2022.814285] [Reference Citation Analysis]
6 Gage M, Putra M, Wachter L, Dishman K, Gard M, Gomez-estrada C, Thippeswamy T. Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress. Antioxidants 2022;11:61. [DOI: 10.3390/antiox11010061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Gage M, Putra M, Gomez-Estrada C, Golden M, Wachter L, Gard M, Thippeswamy T. Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model. Front Cell Neurosci 2021;15:772868. [PMID: 34720886 DOI: 10.3389/fncel.2021.772868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sharma S, Carlson S, Gregory-Flores A, Hinojo-Perez A, Olson A, Thippeswamy T. Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy. Neurobiol Dis 2021;156:105410. [PMID: 34087381 DOI: 10.1016/j.nbd.2021.105410] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
9 Gage MC, Thippeswamy T. Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases. CNS Drugs 2021;35:1-20. [PMID: 33515429 DOI: 10.1007/s40263-020-00787-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]